See what others are discussing and join the conversation.
Top Breast Cancer Research at ASCO 2025 Dr. Eleonora Teplinsky explains DESTINY-Breast09, ASCENT-04, and SERENA-6. Jun 2, 2025 The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting featured five days of presentations and educational sessions on all types of cancer. Dr. Eleonora Teplinsky, a board-certified…
Winter 2025 Breast Cancer Research Round Up Have you been diagnosed with metastatic hormone receptor-positive breast cancer or DCIS? Dr. Kevin Fox discusses the latest research. Apr 18, 2025 Can people diagnosed with metastatic hormone receptor-positive breast cancer avoid chemotherapy and take a CDK4/6 inhibitor instead?…
Testing for ESR1 Mutations, Then Switching to Camizestrant Improves Outcomes for Metastatic HR+ HER2- Breast Cancer May 31, 2025 After two years of follow-up, the new treatment improved survival and quality of life. Read more…
Imlunestrant Plus Verzenio: New Treatment Option for Certain Hormonal Therapy-Resistant Breast Cancers? Dec 20, 2024 Combined with Verzenio, this new oral SERD may be a good option for advanced-stage breast cancer with an ESR1 mutation. Read more…
Hi there i just need to vent my fears. Not even 2 years with MBC and i am about to quit all treatments. Emotional Yo-Yo takes tall. Back in 2016 chemos were rough but i was going for the win. But this time around is different. There is no end of treatment and there is no win per se. I am lost and scared that my next option…
It looks like you're new here. Sign in or register to get started.
These posts are awaiting responses - can you help?
Community Director Melissa Jenkins offers perspective on learning to trust your body again after a breast cancer diagnosis.
Community Director Melissa Jenkins shares tips on how to navigate the special occasions in life that can feel heavy when you’re managing breast cancer.
Community Director Melissa Jenkins shares ways to talk with loved ones about what’s important to you when you’re living with metastatic breast cancer.
Browse our merchandise
We'd love to hear it.